v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
COMMON STOCK
TREASURY STOCK
ADDITIONAL PAID-IN CAPITAL
ACCUMULATED DEFICIT
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Treasury stock (in shares)     0    
Ending balance (in shares)   40,554,705      
Ending balance $ 571,553 $ 4 $ 0 $ 1,140,328 $ (568,779)
Beginning balance (in shares) at Dec. 31, 2024   40,554,705      
Beginning balance at Dec. 31, 2024 571,553 $ 4 $ 0 1,140,328 (568,779)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   7,342      
Exercise of common stock options 4     4  
Stock-based compensation 8,863     8,863  
Net income (loss) 148,451       148,451
Ending balance (in shares) at Mar. 31, 2025     0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Treasury stock (in shares)     0    
Ending balance (in shares)   40,562,047      
Ending balance $ 728,871 $ 4 $ 0 1,149,195 (420,328)
Treasury stock (in shares) (21,126,760)   (21,126,760)    
Ending balance (in shares)   40,670,466      
Ending balance $ 303,132 $ 4 $ (384,558) 1,169,451 (481,765)
Beginning balance (in shares) at Dec. 31, 2025   40,670,466      
Beginning balance at Dec. 31, 2025 $ 303,132 $ 4 $ (384,558) 1,169,451 (481,765)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares) 15,304 15,304      
Exercise of common stock options $ 7     7  
Vesting of restricted stock (in shares)   173,827      
Stock-based compensation 6,199     6,199  
Net income (loss) $ (23,708)       (23,708)
Ending balance (in shares) at Mar. 31, 2026 21,126,760   21,126,760    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Treasury stock (in shares) (21,126,760)   (21,126,760)    
Ending balance (in shares)   40,859,597      
Ending balance $ 285,630 $ 4 $ (384,558) $ 1,175,657 $ (505,473)